PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $64,000 | +3.2% | 24,798 | 0.0% | 0.00% | – |
| Q4 2020 | $62,000 | +63.2% | 24,798 | +34.4% | 0.00% | – |
| Q3 2020 | $38,000 | -33.3% | 18,450 | 0.0% | 0.00% | – |
| Q2 2020 | $57,000 | -3.4% | 18,450 | -29.3% | 0.00% | – |
| Q1 2020 | $59,000 | -37.2% | 26,086 | 0.0% | 0.00% | – |
| Q4 2019 | $94,000 | +23.7% | 26,086 | +17.8% | 0.00% | – |
| Q3 2019 | $76,000 | -26.9% | 22,142 | 0.0% | 0.00% | – |
| Q2 2019 | $104,000 | +40.5% | 22,142 | 0.0% | 0.00% | – |
| Q1 2019 | $74,000 | +25.4% | 22,142 | 0.0% | 0.00% | – |
| Q4 2018 | $59,000 | -52.4% | 22,142 | 0.0% | 0.00% | – |
| Q3 2018 | $124,000 | +10.7% | 22,142 | 0.0% | 0.00% | – |
| Q2 2018 | $112,000 | -16.4% | 22,142 | +12.5% | 0.00% | – |
| Q1 2018 | $134,000 | -10.1% | 19,682 | 0.0% | 0.00% | – |
| Q4 2017 | $149,000 | +31.9% | 19,682 | 0.0% | 0.00% | – |
| Q3 2017 | $113,000 | +13.0% | 19,682 | 0.0% | 0.00% | – |
| Q2 2017 | $100,000 | – | 19,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,196,527 | $16,526,000 | 3.00% |
| BVF INC/IL | 5,328,239 | $27,547,000 | 1.08% |
| Soleus Capital Management, L.P. | 740,000 | $3,826,000 | 0.60% |
| Cutter & CO Brokerage, Inc. | 326,100 | $1,686,000 | 0.40% |
| EAM Investors, LLC | 288,459 | $1,491,000 | 0.25% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $5,316,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,551,000 | 0.11% |
| Navis Wealth Advisors, LLC | 16,000 | $83,000 | 0.06% |
| Sigma Planning Corp | 364,484 | $1,884,000 | 0.06% |
| XTX Topco Ltd | 32,650 | $169,000 | 0.06% |